Conflict of interest: Nothing to declare.
Ikaros deletions in BCR–ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance
Version of Record online: 29 JUN 2014
© 2014 Wiley Periodicals, Inc.
Pediatric Blood & Cancer
Volume 61, Issue 10, pages 1779–1785, October 2014
How to Cite
Vitanza, N. A., Zaky, W., Blum, R., Meyer, J. A., Wang, J., Bhatla, T., Morrison, D. J., Raetz, E. A. and Carroll, W. L. (2014), Ikaros deletions in BCR–ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance. Pediatr. Blood Cancer, 61: 1779–1785. doi: 10.1002/pbc.25119
- Issue online: 19 AUG 2014
- Version of Record online: 29 JUN 2014
- Manuscript Accepted: 7 MAY 2014
- Manuscript Received: 8 APR 2014
- NIH. Grant Numbers: R01 CA140729, R21 CA152838-02, CCSG P30CA016087, T32 CA009161
- American Society of Hematology
- St. Baldrick's Foundation
- Ira Sohn Conference Foundation
Additional supporting information may be found in the online version of this article.
|pbc25119-sm-0001-SupTab-S1.docx||149K||Table SI: Gene Expression Analysis|
|pbc25119-sm-0002-SupTab-S2.docx||40K||Table SII: Gene Ontology Analysis|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.